Reaktion #70875
ord-8683444f98bd490394db1a7f10619b5c
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1EinengenIt was concentrated
- 2workup.ADDITIONa mixture of water and EtOAc
- 3workup.ADDITIONwere added
- 4SonstigeThe phases were separated
- 5ExtraktionThe aqueous phase was extracted with EtOAc
- 6TrocknenThe organic phase was dried over Na2SO4
- 7Einengenconcentrated to dryness
- 8SonstigeThe crude product obtained
- 9Sonstigewas purified by chromatography on silica gel using
- 10Temperaturincreasing polarity mixtures of EtOAc-MeOH as eluent
Vorschrift
In a volumetric flask, 2-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]acetaldehyde (0.08 g, 0.2 mmol, obtained in example 94), sodium triacetoxyborohydride (0.08 g, 0.4 mmol), 4-hydroxypiperidine (0.02 g, 0.2 mmol) and 1,2-dichloroethane (3 mL) were introduced under argon atmosphere. The mixture was stirred overnight at room temperature. It was concentrated and a mixture of water and EtOAc were added. The phases were separated. The aqueous phase was extracted with EtOAc. The organic phase was dried over Na2SO4 and concentrated to dryness. The crude product obtained was purified by chromatography on silica gel using increasing polarity mixtures of EtOAc-MeOH as eluent, to afford 19 mg of the title compound (yield: 20%).